NEW YORK (GenomeWeb News) — As expected, a group of Tripos senior executives will buy the company’s Discovery Research subsidiary for £548,000 ($1.1 million), according to a binding letter of intent the company filed with the US Securities and Exchange commission on April 12.
The company said in March that if a planned sale of the business to Provid Pharmaceuticals were to fall through then some of its management might buy the group themselves.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.